Welcome to our dedicated page for Powerup Acquisition SEC filings (Ticker: PWUPU), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Powerup Acquisition's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Powerup Acquisition's regulatory disclosures and financial reporting.
Aspire Biopharma Holdings, Inc. (NASDAQ: ASBP) filed a Form 8-K to disclose an administrative change of its principal executive office. Effective 17 June 2025, the headquarters moved from Humacao, Puerto Rico, to 23150 Fashion Drive, Suite 232, Estero, Florida 33928. No other operational, financial, or strategic information was presented. The filing contains no updates on earnings, guidance, financing, or material transactions, and therefore is considered a routine corporate housekeeping disclosure.
FAQ
What is the current stock price of Powerup Acquisition (PWUPU)?
